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2 
Abstract 38 
39 
The diverse composition of mammalian tissues poses challenges for understanding the 40 
cell-cell interactions required for organ homeostasis and how spatial relationships are perturbed 41 
during disease. Existing methods such as single-cell genomics, lacking a spatial context, and 42 
traditional immunofluorescence, capturing only 2-6 molecular features, cannot resolve these 43 
issues. Imaging technologies have been developed to address these problems, but each 44 
possesses limitations that constrain widespread use. Here we report a new method that overcomes 45 
major impediments to highly multi-plex tissue imaging. Iterative Bleaching Extends multi-pleXity 46 
(IBEX) uses an iterative staining and chemical bleaching method to enable high resolution imaging 47 
of >65 parameters in the same tissue section without physical degradation. IBEX can be employed 48 
with various types of conventional microscopes and permits use of both commercially available and 49 
user-generated antibodies in an ‘open’ system to allow easy adjustment of staining panels based 50 
on ongoing marker discovery efforts. We show how IBEX can also be used with amplified staining 51 
methods for imaging strongly fixed tissues with limited epitope retention and with oligonucleotide-52 
based staining, allowing potential cross-referencing between flow cytometry, Cellular Indexing of 53 
Transcriptomes and Epitopes by Sequencing (CITE-Seq), and IBEX analysis of the same tissue. 54 
To facilitate data processing, we provide an open source platform for automated registration of 55 
iterative images. IBEX thus represents a technology that can be rapidly integrated into most current 56 
laboratory workflows to achieve high content imaging to reveal the complex cellular landscape of 57 
diverse organs and tissues.  58 
Significance Statement 59 
Single cell flow cytometry and genomic methods are rapidly increasing our knowledge of 60 
the diversity of cell types in metazoan tissues. However, suitably robust methods for placing these 61 
cells in a spatial context that reveal how their localization and putative interactions contribute to 62 
tissue physiology and pathology are still lacking. Here we provide a readily accessible pipeline 63 
(IBEX) for highly multi-plex immunofluorescent imaging that enables a fine-grained analysis of cells 64 
in their tissue context. Additionally, we describe extensions of the IBEX workflow to handle hard to 65 
image tissue preparations and a method to facilitate direct integration of the imaging data with flow 66 
cytometry and sequencing technologies. 67 
68 
Introduction 69 
Mammalian tissues are composed of a wide variety of cell types, presenting a major 70 
challenge to understanding the cell-cell interactions required for homeostasis as well as the 71 
compositional changes associated with disease. To address this complexity, several multi-plexed 72 
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imaging methods utilizing conventional microscopes and commercially available antibodies have 73 
been described to overcome the target detection limitations of conventional immunohistochemistry 74 
(IHC) or immunofluorescence (IF) imaging (1-8). The majority of these methods generate high 75 
dimensional datasets through an iterative, multi-step process (a cycle) that includes: 1) 76 
immunolabeling with antibodies, 2) image acquisition, and 3) fluorophore inactivation or 77 
antibody/chromogen removal. While these methods are capable of generating high dimensional 78 
datasets, they are greatly limited by the number of markers visualized per cycle, length of time 79 
required for each cycle, or involve special fluid-handling platforms not generally available to most 80 
laboratories (1). Commercial systems based on the co-detection by indexing (CODEX) method (9) 81 
have facilitated the acquisition of multi-plex imaging data by providing a fully automated instrument 82 
for cyclic imaging. Despite this advancement, the proprietary nature of this method imposes 83 
constraints on the reagents available for use as well as the number of markers to be imaged for 84 
each round. Furthermore, cyclic imaging methods that employ a small number of markers per cycle 85 
(<3) may result in tissue loss due to the stress of repeated fluid exchanges. To this end, novel 86 
imaging techniques such as multi-plexed ion beam imaging (MIBI) (10) and imaging mass 87 
cytometry (IMC) (11) enable the capture of multi-parameter data without cyclic imaging. However, 88 
both of these methods require specialized instrumentation and consumables, with the latter often 89 
again limited in breadth to choices made by the supplier, not the investigator. This constrains their 90 
capacity for broadly analyzing human or experimental animal tissues with respect to lists of 91 
validated antibodies, the ability to work across various established protocols for tissue processing, 92 
and the capacity for real time changes to the epitope target list based on data emerging from high 93 
content methods such as single cell RNA sequencing (scRNA-Seq).  94 
To facilitate the increasing need for high content analysis of tissues for projects such as 95 
the Human Cell Atlas and others, the field needs a fully open and extensible method for multi-plex 96 
imaging. Our laboratory has extensively characterized murine and human immune responses using 97 
quantitative multi-parameter imaging of fixed frozen samples (12-18). Importantly, this method of 98 
tissue fixation preserves tissue architecture and cellular morphology, is archivable, compatible with 99 
large volume imaging (19), and in its optimal form, eliminates technical challenges posed by 100 
formalin-fixed paraffin embedded (FFPE) samples. Leveraging this experience and our original 101 
single cycle histo-cytometry method for multi-plex data acquisition (12), we have now developed 102 
Iterative Bleaching Extends multi-pleXity (IBEX). This imaging technique reduces the time per 103 
cycle, uses a high number of antibodies per cycle, employs widely available reagents and 104 
instruments, provides open source software for image alignment, and minimizes physical damage 105 
to the tissue during multiple imaging cycles. Beyond the basic IBEX workflow, we have developed 106 
extensions to achieve multi-parameter imaging of heavily fixed tissues with limited retention of 107 
target epitopes and have incorporated commercially available oligonucleotide-conjugated 108 
antibodies to enable direct cross-comparisons to flow cytometry and scRNA-Seq data obtained by 109 
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the Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-Seq) method (20). In 110 
addition to describing the specifics of the IBEX method, we provide multiple examples of the use 111 
of IBEX to analyze both immune and parenchymal cells in a diverse array of mouse and human 112 
tissues to illustrate the general applicability of the method. The IBEX method described here can 113 
be rapidly integrated into current laboratory workflows to obtain high dimensional imaging datasets 114 
of a wide range of animal and human tissues. 115 
116 
Results 117 
118 
IBEX builds and improves upon existing iterative imaging techniques 119 
Iterative imaging methods typically use either fluorophore bleaching or 120 
antibody/chromogen removal to achieve multi-parameter datasets (1-8). Due to the harsh and 121 
variable conditions required to remove chromogens and antibodies with diverse target affinities, we 122 
pursued a strategy based on fluorophore bleaching. To achieve an efficient means to increase the 123 
number of markers visualized on a single section, we sought a fluorophore inactivation method that 124 
could bleach a wide range of fluorophores in minutes without epitope loss or tissue destruction. 125 
While H2O2 in alkaline solution has been reported to inactivate Cy3- and Cy5-conjugated antibodies 126 
in human FFPE samples (3), we observed significant tissue loss using this formulation over multiple 127 
cycles with fixed frozen samples (Fig. S1A). Adams et al. demonstrated the initial feasibility of 128 
borohydride derivates to bleach fluorophores; however, their fluorophore quenching method 129 
required 2 hours per cycle and comprised only 3 distinct imaging channels (6), making direct 130 
application for highly multi-plex imaging impractical. To expand upon this method, we tested 131 
antibodies directly conjugated to fluorophores with excitation and emission spectra spanning from 132 
405 nm to 750 nm. We consistently found that the following fluorophores were inactivated within 133 
15 minutes of exposure to 1 mg/ml of Lithium Borohydride (LiBH4): Pacific Blue, Alexa Fluor 134 
(AF)488, FITC, AF532, Phycoerythrin (PE), AF555, eFluor(eF)570, AF647, eF660, and AF700. 135 
Brilliant Violet conjugates BV421 and BV510 bleached within 15 minutes of exposure to 1 mg/ml of 136 
LiBH4 in the presence of light. In contrast, AF594, eF615, and the nuclear markers JOJO-1 and 137 
Hoechst required more than 120 minutes for significant loss of fluorescence signal (Table S1), 138 
permitting these probes to be used as fiducials for alignment of images emerging from iterative 139 
cycles.  140 
To prevent tissue destruction over multiple cycles, we evaluated several different tissue 141 
adhesives and found that chrome gelatin alum securely adhered tissues to glass coverslips and 142 
slides, permitting more than 15 cycles to be performed with no appreciable loss to the tissue (Fig. 143 
S1B-C). We next reduced the antibody labeling time from 6-12 hours to 30-45 minutes by designing 144 
programs for a non-heating microwave that facilitates rapid antibody penetration into the section. 145 
Finally, although IBEX was designed to simply bleach the fluorophores, it was important to assess 146 
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whether LiBH4 treatment physically removes antibodies from the tissue as this would have direct 147 
bearing on both the design and order of imaging panels. To examine this issue, mouse lymph node 148 
(LN) sections were immunolabeled with various primary antibodies, imaged, treated with LiBH4, 149 
and then incubated with a secondary antibody that would react with the primary antibody if it was 150 
still present on the tissue. For most of the antibody isotypes tested, we found almost identical 151 
staining patterns with the primary and secondary antibodies, indicating that LiBH4 acts primarily by 152 
fluorophore bleaching without stripping the fluorescently conjugated antibodies themselves (Fig. 153 
S2).  154 
The resulting method, IBEX, reduces the fluorophore inactivation and antibody labeling 155 
steps to less than 1 hour (Fig. 1A). We first tested IBEX in practical use by examining the image 156 
quality that could be obtained from a 3 cycle analysis of mouse LNs (Fig. 1B),  a tissue with which 157 
we had extensive experience using multi-parameter, single cycle staining and image collection. 158 
This initial test used 6-8 markers per cycle and showed that all fluorophores, except for AF594 and 159 
JOJO-1, bleached rapidly in the presence of LiBH4 treatment +/- light with no appreciable signal 160 
present after 10 minutes (Fig. 1C-D). These findings show that the IBEX pipeline performs as 161 
designed and allows for the rapid capture of high quality, multi-plexed imaging data over multiple 162 
cycles without tissue loss. 163 
164 
A SimpleITK image registration pipeline 165 
The IBEX method yields a series of images that are collected separately. To properly 166 
process these data and correctly assign markers to individual cells, it is essential that all the images 167 
be aligned at high resolution. While various registration algorithms have been reported (21, 22), we 168 
sought a method that could align large datasets, was flexible in terms of the repeated markers 169 
(fiducials) utilized, and provided both a qualitative and quantitative metric for registration. For these 170 
reasons, we developed a workflow using SimpleITK, a simplified open source interface to the 171 
Insight Toolkit (ITK) that is compatible with multiple programming languages (23, 24). The 172 
SimpleITK workflow is an image intensity-based form of image alignment that relies on a repeated 173 
marker channel (fiducial) for registration. Due to the resistance of AF594, JOJO-1, and Hoechst to 174 
bleaching, we utilized markers in these fluorophores as fiducials. For a multi-cycle IBEX 175 
experiment, a ‘fixed’ image z-stack was selected and all other ‘moving’ images were resampled to 176 
this image. A cross correlation matrix was generated on the repeated marker channels to provide 177 
a quantitative means for assessing the quality of image registration (Fig. 2A). To test the fidelity of 178 
this method, a 3 cycle IBEX experiment was performed on mouse spleen sections labeled with the 179 
nuclear marker JOJO-1 and membrane label CD4 AF594. For these experiments, JOJO-1 was 180 
selected as the fiducial used for image registration; however, CD4 (also repeated in these 181 
experiments) showed pixel-to-pixel alignment as reflected in the images (Fig. 2B). Importantly, this 182 
platform can readily scale to handle large datasets (>260 GB) comprised of 20 cycles of imaging 183 
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(Fig. S1B-D). The SimpleITK registration workflow thus provides the needed cell-cell registration 184 
across x-y-z dimensions obtained via iterative imaging cycles using IBEX. 185 
186 
IBEX is a versatile imaging method 187 
One obstacle to the wide adoption of existing multi-plex imaging methods is the need for 188 
specialized instruments or custom imaging chambers, a luxury not afforded to all laboratories. In 189 
contrast, IBEX is easily adaptable to diverse microscope systems and has no restrictions on the 190 
substrate (slide, coverslip, etc.) used for imaging (Fig. S3A). As a proof-of-concept, immunized 191 
mouse LN sections adhered to slides were visualized using an upright confocal microscope (4 192 
cycles, 6 markers per cycle) or an inverted fluorescence microscope (4 cycles, 4 markers per cycle) 193 
(Fig. S3B-C). These results demonstrate the compatibility of IBEX with a wide range of imaging 194 
systems; however, it is worth noting that the microscope system (confocal versus widefield) and 195 
configuration (light source, detectors, filter cubes) will dictate the image acquisition time, number 196 
of markers per cycle, and sample type that can be effectively  imaged (5 vs. 30 m tissue thickness). 197 
In the case of animal studies, it is also very useful to be able to integrate antibody staining 198 
with imaging of fluorescent marker proteins expressed by engineered cells transferred into animals 199 
or expressed in situ. We therefore next investigated whether the IBEX method could be used to 200 
image tissues from animals expressing fluorescent proteins (25). To this end, high dimensional 201 
imaging was performed on thymic tissues from transgenic animals expressing the following 202 
fluorescent proteins (FPs): cyan (CFP), green (GFP), yellow (YFP), and red (RFP) (26). No 203 
appreciable loss in signal was observed after 10 IBEX cycles for any of the FPs examined (Fig. 204 
S4A-B). The photostable FPs were used as fiducials for a 4 cycle IBEX experiment that 205 
incorporated the bleachable fluorophores AF647 and AF700, yielding a dataset that provided 206 
information on clonality (CFP, GFP, YFP, RFP) of T cells (CD4, CD8, Foxp3) and myeloid cells 207 
(CD11c, MHC II) in the thymus (Fig. S4C). 208 
To determine how IBEX performs using sections from a variety of tissues, we performed 209 
3-5 cycle IBEX experiments on murine spleen, thymus, lung, small intestine, and liver tissue210 
sections (Fig. 3A-B, Movies S1-S5, Table S2). It is important to note that the cycle and marker 211 
numbers described here are provided as a proof-of-concept and do not reflect technical limitations 212 
of the method. The antibody panels were designed to capture the major cellular populations and 213 
structures present in each organ and fluorophores were chosen to avoid native tissue 214 
autofluorescence. Organ-specific fiducials were selected based on expression throughout the 215 
tissue, e.g., EpCAM to mark the epithelium of the small intestine and laminin for the liver sinusoids. 216 
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Collectively, these data confirm the ability to use IBEX to obtain high quality, multi-plexed imaging 217 
datasets from a wide range of tissues.  218 
219 
IBEX enables highly multi-plex, quantitative imaging 220 
The design principles of IBEX were chosen to enable a very high number of parameters to 221 
be attained in the analysis of an individual tissue sample. To determine how extensively the multi-222 
plexing capacity of IBEX can be pushed, we first performed 10 cycle 41 parameter IBEX 223 
experiments on LNs obtained from naïve and sheep red blood cell (SRBC)-immunized mice (Fig. 224 
4A, Table S2, Movie S6). While epitope loss has been described for other iterative imaging 225 
techniques (5), we minimized this problem by increasing the number of markers per cycle and 226 
grouping markers present on the same cell in the same cycle. We observed qualitatively similar 227 
staining patterns when antibody panels were applied on individual sections alone (serial) versus 228 
on the same section iteratively (IBEX) (Fig. S5A and Movie S7). Therefore, quantitative differences 229 
observed between the two methods likely reflect biological differences resulting from variations in 230 
the magnitude of the immune response in individual LNs and not technical differences associated 231 
with epitope loss or steric hindrance (Fig. S5B and Movie S7).  232 
To assess the quality of data generated by the IBEX method, we employed the open 233 
source, computational histology topography cytometry analysis toolbox (histoCAT) to quantify 234 
differences in LN organization resulting from immunization (27). Individual cells were segmented 235 
based on membrane and nuclear labels with Ilastik (28) and CellProfiler (29) and then analyzed 236 
using the histoCAT graphical user interface (GUI) (Fig. S6A). The unsupervised clustering 237 
algorithm Phenograph (30) identified 29 phenotype clusters shared across the naïve and 238 
immunized LNs that could be visualized using the data dimensionality reduction method t-SNE (31) 239 
in histoCAT (Fig. 4B). As a testament to the fidelity of cell-cell alignment, phenotype clusters were 240 
often characterized by the expression of several different markers present in distinct imaging cycles 241 
(Fig. S6B-C). The abundance of these cell phenotypes varied from naïve and immunized LNs (Fig. 242 
S6D) and could be manually annotated based on marker expression to reveal an increase in 243 
plasma cells (PCs) (cluster 10) and germinal center (GC) B cells (cluster 6) in immunized LNs (Fig. 244 
4C). As histoCAT relies on nuclear and membrane-based cell segmentation, it suffers from 245 
limitations frequently encountered with this approach: miscalling of phenotypes due to spatial 246 
overlap and improper segmentation of non-lymphocyte populations (32). The former is evident in 247 
the identification of the B cell specific transcription factor pax5 (33) on CD3+CD4+PD-1+Bcl6+ T 248 
follicular helper (Tfh) cells (cluster 19), an artifact due to the close proximity of these cells within 249 
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the GC (Fig. S6C). Nevertheless, the results presented here demonstrate that IBEX-generated 250 
images are compatible with established methods for analyzing high dimensional imaging data. 251 
252 
IBEX scales to capture ultra-high content data from large areas of human tissues 253 
In addition to capturing the cellular landscape of a diverse range of murine tissues, the 254 
IBEX method scales to enable high content imaging of human tissues. To this end, we present an 255 
application of the IBEX method to visualize tumor-immune interactions in a human pancreatic LN 256 
with metastatic lesions as shown by CD138+EpCAM+ cells in the LN capsule and sinuses (Fig. 5A, 257 
Table S3). Interestingly, cancer cells were segregated from lymphocytes by extensive collagen 258 
remodeling and recruitment of myeloid cells expressing the secreted protein acidic and rich in 259 
cysteine (SPARC), a matricellular glycoprotein involved in extracellular matrix (ECM) deposition 260 
and implicated in metastasis (34). To move to even deeper analysis of a much larger sample, we 261 
used a total of 66 antibodies for the analysis of a > 3mm2 human mesenteric LN section. Using this 262 
approach, we were able to deeply phenotype a wide range of immune cells while observing no 263 
tissue degradation over 20 cycles (Fig. 5B, Movie S8, Table S3). Additionally, we observed 264 
subcellular resolution for PC-specific markers (membrane: CD138, nuclear: IRF4, cytoplasmic: 265 
IgA1, IgA2) present in distinct cycles with no epitope loss, as evidenced by our ability to label the 266 
immune marker CD45 with two different antibody clones present in cycles 9 and 19 (Movie S8). 267 
The utility of this method is further exemplified by our ability to characterize the complex stroma of 268 
the LN, shown to contain 9 distinct clusters in scRNA-Seq experiments from mouse LNs (35), using 269 
a wide range of antibodies visualized in situ: -SMA, CD21, CD23, CD34, CD35, CD49a, CXCL12, 270 
CXCL13, desmin, fibronectin, and vimentin. These data highlight the capacity of IBEX to identify a 271 
large number of distinct cell types in clinically relevant samples, while also placing these 272 
components in a spatial setting missed by methods employing dissociated single cells.  273 
274 
Extensions of IBEX workflow 275 
Given the inherent versatility of the IBEX method, we sought to extend our workflow to 276 
develop two unique protocols, one that enables detection of low abundance epitopes and another 277 
that permits iterative imaging with oligonucleotide-conjugated antibodies corresponding to those 278 
used in scRNA-Seq experiments. Opal IHC, a method of signal amplification that employs 279 
incubation with an unconjugated primary, followed by a horseradish peroxidase (HRP)-conjugated 280 
secondary, and deposition of Opal fluorophore in the tissue, is an attractive method for detection 281 
of very low levels of specific proteins (36). We first tested this method by staining for endogenous 282 
levels of the chemokine CXCL9 in the liver sinusoids of mice (Fig. S7A), which showed a signal not 283 
readily detected with direct or indirect staining methods. Further, because Opal IHC is well 284 
described for the imaging of fixed (FFPE) human tissues (37, 38), we next evaluated whether this 285 
method could be expanded upon to achieve multi-parameter imaging of tissues from high 286 
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containment facilities. Due to the extreme fixation conditions required to inactivate select agents 287 
such as the Ebola virus (10% formalin for 8 days), the majority of stainable epitopes are lost in 288 
these tissues (39, 40). To overcome this significant technical limitation, we developed the Opal-289 
plex method that is based on the IBEX pipeline. Opal-plex extends the usual fluorophore limitations 290 
of Opal by combining multi-plex Opal IHC with cycles of IBEX-based bleaching to eliminate signal 291 
from the following LiBH4-sensitive dyes (Opal 570, 650, and 690) while utilizing the LiBH4-resistant 292 
dye (Opal 540) as a fiducial (Fig. 6A, Fig. S7B). Using this approach, we achieved single cell 293 
resolution of 10 unique markers in heavily fixed mouse LNs (Fig. 6B, Movie S9).  294 
We next evaluated whether oligonucleotide-conjugated antibodies, including those used 295 
for CITE-Seq, are compatible with our IBEX workflow. While immunolabeling with oligonucleotide-296 
conjugated antibodies is well established (9), the use of a large number of commercially available 297 
TotalSeqATM antibodies with publicly available oligo-tag  sequences, the employment of non-298 
proprietary buffers for hybridization and dehybridization, and the use of a wide spectrum of 299 
fluorophore-labeled complementary oligonucleotides provides a truly ‘open source’ system with 300 
many advantages. In particular, the imaging method described here applies the same antibodies 301 
used for scRNA-Seq, permitting direct comparison between imaging and CITE-Seq datasets while 302 
providing a much-needed spatial context for the cell populations identified. Using this approach, 303 
we were able to achieve high quality tissue staining with 5 unique fluorophores (Fig. S7C). This 304 
method can be directly integrated into our IBEX protocol, alongside fluorophore-conjugated 305 
antibodies when CITE-Seq antibodies to desired targets do not exist, as LiBH4 bleaching leaves 306 
oligonucleotide binding intact (Fig. 6C-D). Importantly, the quality of staining achieved with 307 
oligonucleotide-conjugated antibodies, even after multiple cycles of LiBH4 bleaching, is comparable 308 
to conventional IF as quantitative differences, e.g., higher expression of MHCII on DCs versus B 309 
cells, can still be observed (Fig. 6D, Fig. S7D, Movie S9). In summary, this protocol improves upon 310 
existing high dimensional DNA-based imaging techniques by offering full flexibility in antibody-311 
fluorophore pairing, integrating commercially produced CITE-Seq reagents, reducing antibody 312 
labeling to one step, and extending the number of fluorophores per cycle. 313 
314 
Discussion 315 
Multi-plex imaging of tissues is increasingly important for studies of tumor-immune  316 
interactions, for discovery efforts such as the Human Cell Atlas, for better understanding 317 
pathological events in infected or physically damaged tissues, and for placing data from isolated 318 
cells in the context of in situ tissue organization. IBEX is a broadly applicable technique that utilizes 319 
conventional microscopes and commercially available antibodies to obtain these essential high 320 
dimensional imaging data. IBEX improves upon existing iterative methods by addressing many of 321 
the limitations inherent to these techniques. First, we have significantly reduced the fluorophore 322 
inactivation step and antibody labeling time from >16 hours to <1 hour using a rapid chemical 323 
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bleaching agent and antibody labeling employing a commercial, non-heating microwave. Second, 324 
our selection of the bleaching agent LiBH4 provides an efficient means to bleach over 15 unique 325 
fluorophores while preserving select fluorophores to serve as repeated markers for registration. 326 
Importantly, LiBH4 treatment does not cause tissue or epitope loss as evidenced by our ability to 327 
obtain highly multi-plexed data over several cycles in a wide range of tissues with a very large 328 
number of antibodies. Third, and integral to the preservation of tissue integrity through multiple fluid 329 
handling cycles, was the use of the tissue adhesive chrome gelatin alum. Importantly, this adhesive 330 
adheres delicate tissues to the slide or coverslip surface while maintaining key anatomical features. 331 
Finally, the SimpleITK workflow described here represents a significant advancement for the 332 
registration of images obtained via cyclic IF methods. In addition to offering flexibility in terms of 333 
the repeated markers (membrane, nuclear, structural) used, it provides alignment of markers 334 
present on the same cell but not utilized as the fiducial. This is a critical standard for all high 335 
dimensional imaging methods because multiple markers are often required to phenotype a 336 
particular cell type and staining for the relevant epitopes may occur in different imaging cycles.  337 
In addition to developing an efficient method for highly multi-plexed imaging, the IBEX 338 
workflow, unlike commercial all-in-one systems (9-11), offers flexibility in terms of cellular markers, 339 
antibody-fluorophore combinations, and microscope configurations employed. Because the 340 
chemistry of bleaching depends on the fluorophore and not the antibody to which it is conjugated, 341 
once the bleaching conditions are defined, staining panels can be designed using specific 342 
combinations of fluorophores without regard for the target epitopes of the antibodies employed, 343 
providing the user with extreme versatility in experimental design. To this end, we report the 344 
validation of more than 200 commercially available antibodies conjugated to fluorophores with 345 
excitation and emission spectra ranging from 405 nm to 750 nm. Furthermore, we demonstrate that 346 
commercially available oligonucleotide-conjugated antibodies can be seamlessly integrated into 347 
our IBEX workflow, representing the first application of TotalSeqATM antibodies for in situ IHC. 348 
Given that the barcode sequences for TotalSeqATM antibodies are disclosed, and a wide range of 349 
fluorophore-conjugated oligos is readily available, fluorophore and antibody pairing can be fully 350 
customized to match microscope configuration, epitope abundance, and unique tissue 351 
characteristics. Taken together, the oligonucleotide-staining method described here provides a 352 
completely ‘open’ method to achieve highly multi-plexed IF imaging using the same antibodies 353 
employed for flow cytometry and/or CITE-Seq, enabling effective cross-referencing of datasets 354 
derived from these complementary technologies.  355 
As a proof-of-concept, we have used the IBEX workflow to examine such issues as the 356 
visualization of difficult to extract myeloid populations in various tissues, changes in immune cell 357 
composition following immune perturbation, and detection of low abundance epitopes. For the first 358 
application, we were able to visualize tissue-resident macrophages that are difficult to characterize 359 
using other methods such as flow cytometry because of their limited recovery upon enzymatic 360 
11 
tissue digestion (12). Using the panels of antibodies outlined here, we were able to deeply 361 
phenotype medullary (CD169+F4/80+CD11b+Lyve-1+/-) and subcapsular sinus (CD169+F4/80-362 
CD11b+) macrophages in the LNs (41)  as well as alveolar (SiglecF+CD11b-CD11c+ ) and interstitial 363 
(CD11b+CD11c+MHCII+) macrophages of the lung (42). Additionally, we show that the IBEX 364 
method can be scaled to capture ultra-high content imaging in human tissues. The ability to survey 365 
large areas of human tissue is critically important as all possible information needs to be extracted 366 
to provide maximally useful clinical and research data.  367 
Beyond simple visualization of diverse cell types, we have shown compatibility between 368 
IBEX-generated data and downstream single-cell, spatially-resolved analysis using the open 369 
source method histoCAT. From the 10 cycle IBEX experiments described above, the histoCAT 370 
workflow identified 29 phenotype clusters characterized by the expression of several different 371 
markers present in distinct imaging cycles. Importantly, this approach identified well described 372 
changes following immunization such as an increase in Tfh cells and GC B cells (43). Finally, 373 
incorporation of multi-plex Opal IHC into our IBEX workflow facilitated the detection of low 374 
abundance epitopes present in conventionally fixed tissues while aiding in the detection of epitopes 375 
lost under extreme fixation conditions. The latter represents a significant achievement because few 376 
studies have visualized the immunopathology induced by select agents and, to date, the largest 377 
number of parameters examined in a single section has been limited to 3 (44). The ability to use 378 
IBEX in its native format and with the Opal-plex variation is especially valuable in the context of the 379 
current COVID-19 pandemic. Preliminary data show that these methods work well with highly fixed 380 
post-mortem samples from such patients.  381 
In summary, IBEX constitutes a versatile technique for obtaining high content imaging data 382 
using conventional microscopes and commercially available antibodies. In addition to providing a 383 
valuable resource for studying tissue-based immunity in animal models of disease, ongoing studies 384 
have shown the value of the IBEX method to provide a spatially-defined assessment of complex 385 
cell phenotypes from diverse organs including lung, kidney, heart, and lymphoid tissues from 386 
surgical specimens as well as post-mortem samples from human COVID-19 patients. We believe 387 
that the open nature of the reagents that can be utilized, and the variety of instruments suitable for 388 
implementation of IBEX, make it an attractive method for many laboratories seeking to obtain a 389 
deeper understanding of cell composition and spatial organization in tissues of interest. 390 
391 
Materials and Methods 392 
Detailed descriptions of animals, immunization and tissue preparations, reagents, imaging 393 
protocols with Opal fluorophores and oligonucleotide-conjugated antibodies, microscopy 394 
configurations, and image acquisition and analysis details are reported in the SI Materials and 395 
Methods. 396 
397 
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Mouse and human tissues 398 
Murine organs and human LNs (1 cm3 or smaller in size) were fixed with BD 399 
CytoFix/CytoPerm (BD Biosciences) diluted in PBS (1:4) for 2 days. Following fixation, all tissues 400 
were washed briefly (5 minutes per wash) in PBS and incubated in 30% sucrose for 2 days before 401 
embedding in OCT compound (Tissue-Tek). All mice were maintained in specific pathogen-free 402 
conditions at an Association for Assessment and Accreditation of Laboratory Animal Care-403 
accredited animal facility at the National Institute of Allergy and Infectious Diseases (NIAID). All 404 
procedures were approved by the NIAID Animal Care and Use Committee (NIH). De-identified 405 
human LN samples were obtained from patients undergoing elective risk-reducing gastrectomies 406 
or colon resections for colon adenocarcinoma at the National Cancer Institute (NCI) based on an 407 
Institutional Review Board (IRB) approved tissue collection protocol (#13C-0076).  408 
IBEX using inverted confocal microscope 409 
20-30 μm sections were cut on a CM1950 cryostat (Leica) and adhered to 2 well410 
Chambered Coverglasses (Lab-tek) coated with 15 μl of chrome alum gelatin (Newcomer Supply) 411 
per well. Frozen sections were permeabilized, blocked, and stained in PBS containing 0.3% Triton 412 
X-100 (Sigma-Aldrich), 1% bovine serum albumin (Sigma-Aldrich), and 1% mouse or human Fc413 
block (BD Biosciences). For conventional IF, sections were first blocked 1-2 hours at room 414 
temperature and then stained for 12 hours at 4 ̊ C in a humidity chamber. For microwave-assisted 415 
IF, we utilized the PELCO BioWave Pro 36500-230 microwave equipped with a PELCO 416 
SteadyTemp Pro 50062 Thermoelectric Recirculating Chiller (Ted Pella). A 2-1-2-1-2-1-2-1-2 417 
program was used for immunolabeling where ‘2’ denotes 2 minutes at 100 watts and ‘1’ denotes 1 418 
minute at 0 watts. The above program was executed once for blocking and secondary antibody 419 
labeling and twice for primary antibody labeling. A complete list of antibodies and tissue-specific 420 
panels can be found in Tables S1-S5.  Cell nuclei were visualized with JOJO-1 (Thermo Fisher 421 
Scientific) or Hoechst (Biotium) and sections were mounted using Fluoromount G (Southern 422 
Biotech). Mounting media was thoroughly removed by washing with PBS after image acquisition 423 
and before chemical bleaching of fluorophores. Samples were treated with 1 mg/mL of LiBH4424 
(STREM Chemicals) prepared in diH2O for 15 minutes to bleach all fluorophores except JOJO-1, 425 
Hoechst, eF615, and Alexa Fluor 594. To bleach antibodies conjugated to Brilliant Violet 421 426 
(BV421) and Brilliant Violet 510 (BV510) dyes, tissue sections were illuminated using the metal 427 
halide lamp with the DAPI filter of the Leica TCS SP8 X inverted confocal microscope. The 428 
efficiency of fluorophore bleaching was assessed in real time by viewing the LiBH4-incubated 429 
samples on the microscope. Following efficient bleaching, the LiBH4 solution was removed and 430 
samples were washed in 3 exchanges of  PBS, restained with the next panel, and mounted with 431 
Fluoromount G. Fluorophore inactivation with H2O2 was conducted as described previously (5) with 432 
13 
tissue sections being treated for 1 hour at room temperature with 4.5% H2O2 (Sigma) prepared in 433 
an alkaline solution. Tissue sections were imaged as described in the SI Materials and Methods. 434 
435 
Image alignment and registration 436 
The alignment of all IBEX panels to a common coordinate system was performed 437 
using SimpleITK (23, 24). To facilitate registration, we utilized a common channel present in all 438 
panels. As the images may differ by a significant translational motion, we use a Fourier domain-439 
based initialization approach (45) that accommodates for this motion. In addition, we 440 
utilized SimpleITK’s multi-scale registration framework with four levels, reducing the resolution by 441 
a factor of two per level. Directly using the original voxel sizes, on the order of 10-442 
3 mm, in the gradient descent optimizer computations leads to numerical instability. We therefore 443 
normalized the voxel dimensions during optimization, while preserving anisotropy. The final, 444 
optimal transformations are then used to resample all channels from each panel to the common 445 
coordinate system. The software repository for SITK_IBEX can be found on github.com/niaid/sitk-446 
ibex. 447 
448 
Extensions of IBEX protocol 449 
Integrating IBEX with Opal dyes or oligonucleotide-conjugated antibodies was performed 450 
as detailed in the SI Materials and Methods. For multi-plex Opal IHC the following steps—primary 451 
antibody incubation, incubation with HRP-conjugated secondary, labeling with Opal dye, and 452 
antibody stripping—were repeated to achieve 6-plex imaging using the Opal 520, 540, 570, 620, 453 
650, and 690 fluorophores. After representative images were captured, coverslips were removed 454 
and tissue sections were treated with 1 mg/mL of LiBH4 prepared in diH2O for 30 minutes to bleach 455 
the Opal 570, 650, and 690 dyes. Cycles of multi-plex Opal IHC and IBEX were repeated to achieve 456 
the desired number of markers. For integration of oligonucleotide-conjugated antibodies into the 457 
IBEX workflow, TotalSeq-A™ antibodies were co-incubated with fluorophore-conjugated antibodies 458 
which were imaged first before LiBH4 bleaching. Oligonucleotides are preserved and 459 
complementary fluorophore-conjugated oligonucleotides are used to reveal immunostaining, then 460 
either dehybridized or bleached again in situ across multiple cycles. 461 
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577 
Figure 1. IBEX: A high dimensional, iterative imaging technique. 578 
(A) Schematic depicting IBEX protocol using an inverted confocal microscope. (B) Mice were579 
immunized s.c. with 25 µl of SRBCs on day 0 and 7. On day 14, pLN tissue sections were labeled580 
with 3 separate imaging panels. JOJO-1 and CD4 AF594 were present throughout cycles 1-3 and581 
served as fiducials.  Left-most panel is a composite of all channels except for JOJO-1. Scale bar582 
represents 150 µm. Light refers to bleaching with LiBH4 while sample was illuminated with a metal583 
halide lamp and DAPI filter (C) Time required to bleach respective fluorophores using LiBH4. NA584 
indicates no appreciable loss of signal over multiple hours of LiBH4 exposure. (D) Percentage of585 
17 
fluorophore signal remaining after 15 minutes of LiBH4 treatment. Data are pooled from 2 similar 586 
experiments. 587 
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Figure 2. Image alignment with SimpleITK image registration pipeline. 617 
(A) Workflow for SimpleITK image registration pipeline. (B) Confocal images showing JOJO-1 and618 
CD4 from 3 consecutive IBEX cycles before and after alignment using the nuclear marker JOJO-1619 
as a fidicual across all 3 cycles. CD4 was also repeated and shows cell-cell registration after JOJO-620 
1 alignment. Cycle (C), scale bar is 50 µm. Cross correlation similarity matrices before and after621 
alignment with JOJO-1 for JOJO-1 and CD4 channels. All experiments are representative of at622 
least 2 similar experiments.623 
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627 
Figure 3. IBEX in multiple murine organs. 628 
20 
(A) IBEX experimental parameters. (B) Confocal images from IBEX experiments in various mouse629 
organs. Liver: central vein (CV) and glutamine synthetase (GS). Scale bar is 100 µm. See Movies630 
S1-S5 for additional details.631 
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683 
Figure 4. Visualization and quantification of LN populations using IBEX and histoCAT 684 
following immune perturbation. 685 
686 
(A) Confocal images of pLNs from naïve and SRBC-immunized mice from 10 cycle (C) 41687 
parameter IBEX experiments, GC (germinal center), NK (natural killer), FDC (follicular dendritic688 
cell), PC (plasma cells). Scale bars from left to right: 100 µm, 25 µm, 100 µm, and 50 µm. (B) t-689 
SNE plots from naïve and immunized LNs identified by Phenograph clustering using segmented690 
cells in histoCAT (naïve n = 32,091; immune n = 80,355). Color reflects the cluster ID number (1-691 
29). Single plots show separation of representative markers into discrete clusters with color map692 
showing relative expression levels based on Z-score normalized marker intensity values. (C)693 
Phenograph clusters identified by histoCAT were phenotyped based on marker expression and694 
expressed as a proportion of lineage. Tfh (T follicular helper), MΦ (macrophage), SCS (subcapsular695 
sinus), MSM (Medullary sinus), DC (dendritic cell), dDC (dermal DC). Data are from one experiment696 
and representative of 2 similar experiments. See Fig. S6 and Movie S6.697 
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704 
Figure 5. IBEX scales to capture ultra-high content imaging in human tissues. 705 
(A) Confocal images from a pancreatic LN with metastatic lesions from a patient with colorectal706 
cancer (4 cycle 17 parameter IBEX experiment). Scale bar is 500 µm (left), 100 µm (Box 1), or 50707 
µm (Box 2). (B) Representative confocal images from human mesenteric LN obtained by IBEX708 
method (20 cycle 66 parameters). Scale bars (500 or 50 µm). Fibronectin (Fibro), Laminin (Lamin).709 
See Movie S8 for additional details.710 
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Figure 6. Incorporation of Opal fluorophores and oligo-conjugated antibodies into IBEX 721 
workflow. 722 
(A) Opal-plex imaging method consisting of several rounds of labeling with marker-specific primary723 
antibodies, an HRP-conjugated secondary antibody, Opal dyes, and antibody stripping for each724 
marker-Opal fluorophore pair followed by cycles of IBEX (imaging, removal of coverslip, and725 
bleaching). (B) Representative images from a 10 parameter 4 cycle Opal-plex experiment726 
24 
performed on 5 µm FFPE tissue sections from heavily fixed mouse pLNs. CD3 Opal 540 was 727 
present throughout cycles 1-4 and served as a fiducial (*). Scale bars (200 µm, left-most panel or 728 
50 µm). (C) Schematic depicting principle behind tissue imaging with oligo-conjugated antibodies 729 
and incorporation of these reagents into IBEX workflow. (D) Confocal images from a 13 parameter 730 
3 cycle IBEX experiment performed on 20 µm tissue sections from an immunized inguinal mouse 731 
LN. Cycle 1: Fluorophore-conjugated antibodies. Cycles 2-3: Oligo-conjugated antibodies, Atto550 732 
(AT550). Scale bars (400 µm, top-left panel or 50 µm). Data are representative of 3 similar 733 
experiments. See Fig. S7 and Movie S9. 734 
